相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Study design factors influencing patients' willingness to participate in clinical research: a randomised vignette-based study
Angele Gayet-Ageron et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Online Patient Recruitment in Clinical Trials: Systematic Review and Meta-Analysis
Mette Brogger-Mikkelsen et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2020)
Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015-2016
Yao Qiao et al.
CLINICAL TRIALS (2019)
Estimating Site Performance (ESP): can trial managers predict recruitment success at trial sites? An exploratory study
Hanne Bruhn et al.
TRIALS (2019)
What drives site performance in clinical trials?
Brendan Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Quantifying and visualizing site performance in clinical trials
Eric Yang et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
David B. Fogel
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
TRIAL WATCH Trends in clinical trial design complexity
Kenneth A. Getz et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013
Sohyun Jeong et al.
TRIALS (2017)
Statistical challenges for central monitoring in clinical trials: a review
Koji Oba
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Good Clinical Practice Guidance and Pragmatic Clinical Trials Balancing the Best of Both Worlds
Robert J. Mentz et al.
CIRCULATION (2016)
Key cost drivers of pharmaceutical clinical trials in the United States
Aylin Sertkaya et al.
CLINICAL TRIALS (2016)
Assessing site performance in the Altair study, a multinational clinical trial
Nisha Berthon-Jones et al.
TRIALS (2015)
Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials
Benjamin Carlisle et al.
CLINICAL TRIALS (2015)
Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials
Ignacio Atal et al.
PLOS ONE (2015)
Prevalence, Characteristics, and Publication of Discontinued Randomized Trials
Benjamin Kasenda et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Improving Protocol Design Feasibility to Drive Drug Development Economics and Performance
Kenneth Getz
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2014)
Benchmarking the Study Initiation Process
Mary Jo Lamberti et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2013)
Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from US Cooperative Oncology Groups
Anneke T. Schroen et al.
CLINICAL CANCER RESEARCH (2012)
Disclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research Transparency
Rafael Dal-Re et al.
PLOS MEDICINE (2011)